JPRN-UMIN000007087已完成未知
The Efficacy Study of Neoadjuvant Xelox in Patients with Locally Advanced Lower Rectal Cancer - Neoadjuvant Xelox for locally advanced rectal cancer
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 30 人开始时间: 2012年1月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Lateral node involvement 2. Cancerous fluid 3. Active infectious disease 4. Concomitant malignancy (within 5 years) and double cancer 5. Uncontrolled diabetic 6. Peripheral neuropathy 7. Serious lung disease 8. Clinically significant cardiac disease 9. Pregnant women and nursing mothers, possibly pregnant women, and men attempting to conceive a child 10. Other conditions judged ineligible by physician
研究者
相似试验
已完成
2 期
Phase2 study of perioperative XELOX in patients with locally-advanced lower rectal cancerRectal cancerJPRN-UMIN000008203Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group44
招募中
2 期
Phase II study of XELOX as adjuvant chemotherapy for locally advanced rectal cancerocally advanced rectal cancerJPRN-UMIN000008429Chubu Clinical Oncology Group(CCOG)40
已完成
不适用
Pilot study of preoperative chemotherapy of XELOX+ Bevacizumab in patients with locally-advanced lower rectal cancerRectal cancerJPRN-UMIN000003219Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group20
Unknown
3 期
Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisResectable Liver MetastasisColorectal CancerNCT00630045Peking University People's Hospital392
已完成
2 期
A randomized phase II study of XELOX plus Bevacizumab versus XELIRI plus Bevacizumab for advanced colorectal cancer with or without mitochondrial transcription factor A (mtTFA) expression.nresectable advanced/recurrent colorectal cancerJPRN-UMIN000005060Fukuoka University Hospital100